DXB 9.91% 61.0¢ dimerix limited

Ann: Notification of upcoming expiry of Unlisted Options, page-50

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    if you look at the drivers of big Pharma acquisitions they’re usually based on the target having a compelling pipeline (eg suite of antibody drug conjugates in oncology) or a standout groundbreaking drug like the Crown Jewels
    ——Dmx fits neither of those.
    ——/Beyond this trial the larder looks bare, and the dimx drug itself performing better than a placebo when other drugs in this space outperform it, well I can’t see Big Pharma boardrooms getting excited.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
61.0¢
Change
0.055(9.91%)
Mkt cap ! $335.3M
Open High Low Value Volume
57.0¢ 61.5¢ 56.5¢ $1.938M 3.305M

Buyers (Bids)

No. Vol. Price($)
1 3652 60.5¢
 

Sellers (Offers)

Price($) Vol. No.
61.0¢ 27035 1
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.